Iron is essential for numerous biological processes, including oxygen transport, DNA synthesis, and cellular respiration. However, maintaining iron balance is crucial, as both iron deficiency and iron overload can lead to severe health issues. At the Laboratory of Iron Homeostasis, we investigate the mechanisms that regulate iron metabolism, focusing on iron recycling, sensing, and its impact on immune function and disease progression.

Research Summary

One aspect of our research focuses on iron recycling, mainly orchestrated by splenic red pulp macrophages (RPMs) that break down aging erythrocytes, releasing iron into the bloodstream. Despite being the primary iron source, limited knowledge exists about RPMs and the mechanisms influencing iron turnover efficacy. Our recent findings highlight the impairment of this process during aging. We demonstrated that age-related iron deposition in RPMs leads to their failure and demise, a challenge mitigated by dietary iron restriction in mice.

Another project explores unique functional and metabolic changes in RPMs in response to iron deficiency, aiding the organism's adjustment to restricted iron supplies. Concurrently, we investigate novel mechanisms in the sensing of body iron levels, particularly by specialized liver endothelial cells known as LSECs. We uncovered a new signaling pathway involving MAP kinases and the transcription factor ETS1, activated by excessive iron to amplify the expression of the well-known "iron sensor" Bmp6. Additionally, our research identifies LSECs as the primary cells removing free hemoglobin from circulation, playing a role in physiological iron recycling and hemoglobin detoxification under hemolytic conditions.

Scientific Impact

  • - Identified impairment of iron recycling as an early hallmark of aging.
  • - Discovered a new signaling pathway involved in iron sensing by liver endothelium.
  • - Uncovered a previously unknown role of liver endothelium in the clearance of free hemoglobin, operating both under physiological and hemolytic conditions.

 

Future Goals

  • - Explore the connections between iron recycling efficiency and splenic immune functions.
  • - Deepen our understanding of the diverse roles of liver endothelium in maintaining iron homeostasis.
  • - Further explore the adaptation of splenic macrophages to iron deficiency in health and disease.

 

Comment

"In our research, what we find particularly exciting is to realize that certain “dogmas” may only be partially accurate or even entirely false. This not only challenges existing beliefs but also creates opportunities to discover new principles in mammalian physiology that remain incompletely understood.", says Dr. Katarzyna Mleczko-Sanecka.


LHZ picture

Primary murine LSECs performing uptake of fluorescentlylabeled hemoglobin. Illustration by Aneta Jończy.

sanecka

Katarzyna Mleczko-Sanecka, PhD 

Correspondence address:
Laboratory of Iron Homeostasis
International Institute of Molecular and Cell Biology
4 Ks. Trojdena Street, 02-109 Warsaw, Poland
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
tel: +48 (22) 597 0776; fax: +48 (22) 597 0715

DEGREES

2011 - PhD in Biology, European Molecular Biology Laboratory (EMBL) Heidelberg and Heidelberg University, Germany
2007 - MSc in Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Cracow, Poland

PROFESSIONAL EXPERIENCE

2017-present - Professor, Head of Laboratory of Iron Homeostasis, International Institute of Molecular and Cell Biology in Warsaw, Poland
2011-2015 - Postdoctoral research with Prof. Martina Muckenthaler and Prof. Matthias W. Hentze, Molecular Medicine Partnership Unit, European Molecular Biology Laboratory and Heidelberg University, Heidelberg, Germany
2007-2011 - Doctoral research with Prof. Martina Muckenthaler and Prof. Matthias W. Hentze, Molecular Medicine Partnership Unit, European Molecular Biology Laboratory and Heidelberg University, Heidelberg, Germany
2006-2007 - Master thesis research with Prof. Józef Dulak and Prof. Alicja Józkowicz, Department of Medical Biotechnology, Jagiellonian University, Cracow, Poland
2006 - Undergraduate research during Erasmus fellowship with Dr. Claudine Kieda, Centre De Biophysique Moleculaire, Centre National de la Recherche Scientifique, Orleans, France
2005 - Undergraduate research during Erasmus scholarship with Dr. Claudine Kieda, Centre De Biophysique Moleculaire, Centre National de la Recherche Scientifique, Orleans, France

HONORS, PRIZES AND AWARDS

2023 - Awarded as a Co-investigator in the American Federation for Aging Research (AFAR) grant
2023 - Gunshin Levy Award from the BioIron Society
2021 - NCN SONATA BIS 10 Grant
2020 - Scholarship of the Minister of Science and Higher Education for Outstanding Young Scientist
2019 - NCN OPUS 16 Grant
2016 - POLONEZ, National Science Centre
2014 - Independent research grant, University of Heidelberg
2011 - Invitation to 61st Lindau Meeting of Nobel Laureates, Lindau, Germany
2015, 2014, 2011-2009 - Travel Grant to attend and present data at the international conferences in iron biology
2007 - Louis-Jeantet PhD Scholarship for young researchers from Eastern Europe to support PhD studies at European Molecular Biology Laboratory
2006 - Erasmus Scholarship, Centre National de la Recherche Scientifique, Orleans, France

team2019

Lab Leader:

  • Katarzyna Mleczko-Sanecka, PhD

PhD Students:

  • Pratik Kumar Mandal, MSc

  • Komal Kumari Chouhan, MSc

  • Raghunandan Mahadeva, MSc

Post-doc:

  • Aneta Jończy, PhD

Research Technician:

  • Marta Niklewicz (part-time)

Technician:

  • Krzysztof Franczak (part-time)

Laboratory Support Specialist:

  • Anna Grabowska, PhD (part-time)

2025

Effects of genetic ablation and pharmacological inhibition of HuR on gene expression, iron metabolism, and hormone levels.

Idlin N, Krishnamoorthy S, Wolczyk M, Fakhri M, Lechowski M, Stec N, Milek J, Mandal PK, Cendrowski J, Spanos C, Dziembowska M, Mleczko-Sanecka K, Rappsilber J, Michlewski G.

BMC Biol. 2025

2024

Iron-triggered signaling via ETS1 and the p38/JNK MAPK pathway regulates Bmp6 expression.

Zurawska G, Jończy A, Niklewicz M, Sas Z, Rumieńczyk I, Kulecka M, Piwocka K, Rygiel TP, Mikula M, Mleczko-Sanecka K.

Am J Hematol. 2024

2023

Impaired iron recycling from erythrocytes is an early hallmark of aging.

Slusarczyk P, Mandal PK, Zurawska G, Niklewicz M, Chouhan K, Mahadeva R, Jończy A, Macias M, Szybinska A, Cybulska-Lubak M, Krawczyk O, Herman S, Mikula M, Serwa R, Lenartowicz M, Pokrzywa W, Mleczko-Sanecka K.

eLife. 2023

Anemia, Iron Deficiency, and Iron Regulators in Pancreatic Ductal Adenocarcinoma Patients: A Comprehensive Analysis.

Osmola M, Gierej B, Mleczko-Sanecka K, Jończy A, Ciepiela O, Kraj L, Ziarkiewicz-Wróblewska B, Basak GW.

Curr Oncol.. 2023

Liver sinusoidal endothelial cells constitute a major route for hemoglobin clearance.

Zurawska G, Sas Z, Jończy A, Slusarczyk P, Mahadeva R, Chwałek M, Kulecka M, Rumieńczyk I, Moulin M, Jastrzębski K, Mikula M, Etzerodt A, Miączyńska M, Rygiel TP, Mleczko-Sanecka K.

bioRxiv. 2023

2021

Cell-type-specific insights into iron regulatory processes.

Mleczko-Sanecka K, Silvestri L.

Am J Hematol.. 2021

The Multiple Facets of Iron Recycling.

Slusarczyk P, Mleczko-Sanecka K.

Genes (Basel). 2021

2017

Imatinib and spironolactone suppress hepcidin expression

Mleczko-Sanecka K, da Silva AR, Call D, Neves J, Schmeer N, Damm G, Seehofer D, Muckenthaler MU

Haematologica. 2017

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3

Pasricha SR, Lim PJ, Duarte TL, Casu C, Oosterhuis D, Mleczko-Sanecka K, Suciu M, Da Silva AR, Al-Hourani K, Arezes J, McHugh K, Gooding S, Frost JN, Wray K, Santos A, Porto G, Repapi E, Gray N, Draper SJ, Ashley N, Soilleux E, Olinga P, Muckenthaler MU, Hughes JR, Rivella S, Milne TA, Armitage AE, Drakesmith H.

Nat Commun. 2017